Sanifo, Pfizer, Bristol-Myers Squibb, Samsung BioLogics, Eli Lilly and Bayer HealthCare
– PMLive’s Sanofi Israel Crowdsources New Diabetes App reports Sanofi is collaborating with Camoni – an Israeli social network for patients – to crowdsource ideas for a new mobile app for people with diabetes. While Sanofi said that this type of crowdsourcing initiative was the first of its kind, the campaign is not the company’s first foray into the world of mobile apps, being among the first in pharma to use the technology with its diabetes arm developing first the GoMeals iPhone app in 2009
– Pfizer announced plans to move forward to internally separate its commercial operations into three business segments, two of which will include Innovative business lines and a third which will include the Value business line. Pfizer To Create Separate, Internal, Global Innovative And Value Businesses explains each of the three segments will include developed markets and emerging markets
– World Pharma News reports that Bristol-Myers Squibb and Samsung BioLogics Announce Biopharmaceutical Manufacturing Relationship, with the companies entering into a 10-year agreement under which Samsung BioLogics will manufacture a commercial antibody cancer drug for Bristol-Myers Squibb at its recently completed plant in Songdo Incheon, South Korea
– For over 135 years, Eli Lilly and Company has committed itself to discovering and developing innovative medicines to help realize their vision “to make a significant contribution to humanity by improving global health in the 21st century”. pharmaphorum’s A History of… Eli Lilly & Co looks into the history of Eli Lilly and Company, which has a strong commitment to developing and discovering new drugs in the areas of diabetes, neuroscience, cardiovascular diseases and oncology
– Bayer HealthCare initiates and supports many cooperation projects that are committed to improving health care. Bayer Donates Antibiotic to Project HOPE to Improve Health Care for Tens of Thousands in Zanzibar announces Project HOPE UK will receive the antibiotic ciprofloxacin, donated by Bayer HealthCare, to improve health care for underserved communities for as many as 40,000 patients in Zanzibar
